These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 30256411)
1. Heme oxygenase-1 reduces the sensitivity to imatinib through nonselective activation of histone deacetylases in chronic myeloid leukemia. Wei D; Lu T; Ma D; Yu K; Li X; Chen B; Xiong J; Zhang T; Wang J J Cell Physiol; 2019 Apr; 234(4):5252-5263. PubMed ID: 30256411 [TBL] [Abstract][Full Text] [Related]
2. Heme oxygenase-1 contributes to imatinib resistance by promoting autophagy in chronic myeloid leukemia through disrupting the mTOR signaling pathway. Cao L; Wang J; Ma D; Wang P; Zhang Y; Fang Q Biomed Pharmacother; 2016 Mar; 78():30-38. PubMed ID: 26898422 [TBL] [Abstract][Full Text] [Related]
3. Induction of heme oxygenase-1 by Na+-H+ exchanger 1 protein plays a crucial role in imatinib-resistant chronic myeloid leukemia cells. Ma D; Fang Q; Wang P; Gao R; Wu W; Lu T; Cao L; Hu X; Wang J J Biol Chem; 2015 May; 290(20):12558-71. PubMed ID: 25802333 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of heme oxygenase-1 in bone marrow stromal cells promotes microenvironment-mediated imatinib resistance in chronic myeloid leukemia. Liu P; Ma D; Yu Z; Zhe N; Ren M; Wang P; Yu M; Huang J; Fang Q; Wang J Biomed Pharmacother; 2017 Jul; 91():21-30. PubMed ID: 28445830 [TBL] [Abstract][Full Text] [Related]
5. Targeting of heat shock protein 32 (Hsp32)/heme oxygenase-1 (HO-1) in leukemic cells in chronic myeloid leukemia: a novel approach to overcome resistance against imatinib. Mayerhofer M; Gleixner KV; Mayerhofer J; Hoermann G; Jaeger E; Aichberger KJ; Ott RG; Greish K; Nakamura H; Derdak S; Samorapoompichit P; Pickl WF; Sexl V; Esterbauer H; Schwarzinger I; Sillaber C; Maeda H; Valent P Blood; 2008 Feb; 111(4):2200-10. PubMed ID: 18024796 [TBL] [Abstract][Full Text] [Related]
6. Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines. Sorrenti V; Pittalà V; Romeo G; Amata E; Dichiara M; Marrazzo A; Turnaturi R; Prezzavento O; Barbagallo I; Vanella L; Rescifina A; Floresta G; Tibullo D; Di Raimondo F; Intagliata S; Salerno L Eur J Med Chem; 2018 Oct; 158():937-950. PubMed ID: 30261468 [TBL] [Abstract][Full Text] [Related]
8. Nuclear translocation of heme oxygenase-1 confers resistance to imatinib in chronic myeloid leukemia cells. Tibullo D; Barbagallo I; Giallongo C; La Cava P; Parrinello N; Vanella L; Stagno F; Palumbo GA; Li Volti G; Di Raimondo F Curr Pharm Des; 2013; 19(15):2765-70. PubMed ID: 23092325 [TBL] [Abstract][Full Text] [Related]
9. Synergistic activity of imatinib and AR-42 against chronic myeloid leukemia cells mainly through HDAC1 inhibition. Wei D; Lu T; Ma D; Yu K; Zhang T; Xiong J; Wang W; Zhang Z; Fang Q; Wang J Life Sci; 2018 Oct; 211():224-237. PubMed ID: 30248347 [TBL] [Abstract][Full Text] [Related]
10. Betulinic acid restores imatinib sensitivity in BCR-ABL1 kinase-independent, imatinib-resistant chronic myeloid leukemia by increasing HDAC3 ubiquitination and degradation. Lu T; Wei D; Yu K; Ma D; Xiong J; Fang Q; Wang J Ann N Y Acad Sci; 2020 May; 1467(1):77-93. PubMed ID: 31930541 [TBL] [Abstract][Full Text] [Related]
11. microRNA-199a/b-5p enhance imatinib efficacy via repressing WNT2 signaling-mediated protective autophagy in imatinib-resistant chronic myeloid leukemia cells. Chen PH; Liu AJ; Ho KH; Chiu YT; Anne Lin ZH; Lee YT; Shih CM; Chen KC Chem Biol Interact; 2018 Aug; 291():144-151. PubMed ID: 29890129 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of Smad4 expression confers chemoresistance against imatinib mesylate to chronic myeloid leukemia K562 cells. Zhang J; Zhang M; Liang Y; Liu M; Huang Z Hematology; 2022 Dec; 27(1):43-52. PubMed ID: 34957936 [No Abstract] [Full Text] [Related]
13. Sonic hedgehog signaling regulates Bcr-Abl expression in human chronic myeloid leukemia cells. Liao HF; Su YC; Zheng ZY; Jhih Cai C; Hou MH; Chao KS; Chen YJ Biomed Pharmacother; 2012 Jul; 66(5):378-83. PubMed ID: 22397755 [TBL] [Abstract][Full Text] [Related]
14. PBA2, a novel inhibitor of imatinib-resistant BCR-ABL T315I mutation in chronic myeloid leukemia. Gupta P; Kathawala RJ; Wei L; Wang F; Wang X; Druker BJ; Fu LW; Chen ZS Cancer Lett; 2016 Dec; 383(2):220-229. PubMed ID: 27720778 [TBL] [Abstract][Full Text] [Related]
15. Identification of heme oxygenase-1 as a novel BCR/ABL-dependent survival factor in chronic myeloid leukemia. Mayerhofer M; Florian S; Krauth MT; Aichberger KJ; Bilban M; Marculescu R; Printz D; Fritsch G; Wagner O; Selzer E; Sperr WR; Valent P; Sillaber C Cancer Res; 2004 May; 64(9):3148-54. PubMed ID: 15126353 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of Deng Y; Li X; Feng J; Zhang X Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29559564 [TBL] [Abstract][Full Text] [Related]
17. Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia. Zeng X; Zhao H; Li Y; Fan J; Sun Y; Wang S; Wang Z; Song P; Ju D Autophagy; 2015; 11(2):355-72. PubMed ID: 25701353 [TBL] [Abstract][Full Text] [Related]
18. Secretion of IL-1β from imatinib-resistant chronic myeloid leukemia cells contributes to BCR-ABL mutation-independent imatinib resistance. Lee CR; Kang JA; Kim HE; Choi Y; Yang T; Park SG FEBS Lett; 2016 Feb; 590(3):358-68. PubMed ID: 26831735 [TBL] [Abstract][Full Text] [Related]
19. [Growth inhibition and differentiation of imatinib-resistant chronic myeloid leukemia cell induced by cell differentiation agent in vitro]. Wang XD; Qiu L; Lu RZ; Chen LJ; Zhan ZM; Han BH; Zhang BL; Ma J Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(48):3399-405. PubMed ID: 18476538 [TBL] [Abstract][Full Text] [Related]
20. HDAC inhibitor suppresses proliferation and tumorigenicity of drug-resistant chronic myeloid leukemia stem cells through regulation of hsa-miR-196a targeting BCR/ABL1. Bamodu OA; Kuo KT; Yuan LP; Cheng WH; Lee WH; Ho YS; Chao TY; Yeh CT Exp Cell Res; 2018 Sep; 370(2):519-530. PubMed ID: 30017934 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]